Improving patient access to novel cancer drugs in Australia: striking the balance

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1121232

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cancer patients in Australia may experience delays before they can benefit from new expensive drugs because of the lengthy existing processes to evaluate new medicines by the Department of Health. I will study how to improve the existing drug evaluation processes to make timely but informed funding decisions. This work will improve patient outcomes from early access to effective new cancer drugs and help the government make a wiser spending of public funds.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Health Economics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

haematology | health policy evaluation | health service decision making | oncology | public health policy

Related Links